GEN Exclusives

More »

GEN News Highlights

More »
Sep 11, 2009

Innate Pharma to Leverage French Research Through Alliance with Inserm

  • Innate Pharma negotiated a deal with Inserm, France’s health research agency, giving the company early access and potential licensing options to antibody target projects in development by Inserm laboratories. The partnership is reportedly the first of its kind undertaken by Inserm.

    The agreement was made via Inserm’s technology transfer arm, Inserm-Transfert. This means that Innate will be regularly updated about new antibody targets discovered by Inserm laboratories. Inserm-Transfert will also help to identify high-potential products from different Inserm laboratories. 

    After preliminary evaluation of promising projects, the company will have the opportunity to collaborate with Inserm on further development. Project-specific option agreements will also give Innate the right to license products for development.

    The organizations claim that this new kind of partnership will benefit from the combination of Inserm’s specialization in fundamental research and Innate’s expertise in translational research in antibody development. They suggest the continuous interaction between Inserm and Innate will help ensure that the most promising research programs are selected for further development.

    “Facilitating collaboration between Inserm’s academic laboratories and industry is at the core of Inserm-Transfert’s mission,” comments Cécile Tharaud, Ph.D., Inserm-Transfert’s CEO. “In this kind of partnership, our partners benefit from our high value-added services within a streamlined, contractual relationship.”



GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »